About Artelon
Artelon is a Healthcare company based in Marietta (United States) founded in 1986 by Lars Peterson, and was acquired by Stryker in June 2024. Regenerative biomaterials for tendon and ligament reconstruction are developed. Artelon has raised $20 million across 1 funding round from investors including Stryker and Vensana Capital. Its chief executive, as recorded, is Aaron Smith. Artelon offers products and services including FLEXBAND. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Diversified. Its competitors include Theradaptive, Aziyo Biologics and MiMedx Group; 2 of its 3 listed competitors have raised funding.
Company details
Artelon was founded in 1986 and is headquartered in Marietta, United States. Biomaterials are developed by the company for regenerative medicine, targeting soft tissue reconstruction in tendons and ligaments. Solutions are provided for pain management, functional restoration, arthritis treatment, and deformity correction. Elasticity is enhanced in healing tissues to support natural motion, within the medical devices and biotechnology sector.
Products & Services of Artelon
Artelon offers a comprehensive portfolio of products and services, including FLEXBAND.
Enhances strength of repaired tissues for ankle stability.
Funding Insights of Artelon
Artelon has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series B round of $20 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20M
- Total Rounds 1
- Last Round Series B — $20M
- First Round $20M
(May 2023)
- Investors Count 1
All 1 funding rounds of Artelon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2023 | $20M | Series B | – | Vensana Capital | – |
2 investors in total: 2 institutional.
Investors in Artelon
Artelon has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker and Vensana Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in medical technology are made by Vensana Capital. | vensanacap.com | Minneapolis, United States | ||
3D-printed orthopedic products are manufactured for medical applications. | 1941 | stryker.com | Kalamazoo, United States |
Investor details for Artelon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Artelon
10 people are tracked at Artelon (5 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Lars Peterson | Founder | Leadership |
Aaron Smith | CEO | Leadership |
Zachary Leder | CEO | Leadership |
Chris Dellelo | Area Sales Director - Boston | Leadership |
Michael Pandolfi | Regional Vice President Of Sales | Leadership |
Tara Aycock Newton | Controller | Team |
Eugenio Ferrario | Senior Process Development Engineer | Team |
Todd Goede | EVP Innovation And Manufacturing | Team |
Tony Calandra | Sales Specialist | Team |
Gracie Siniard | Sr. Technical Operations Technician | Team |
Complete people profiles for Artelon
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Artelon
3 dated milestones of Artelon across 38 years, from founding to its latest funding, stage changes and deals.
- Founded Artelon is founded.
- Funding First funding round of $20.0M.
- Exit Acquired by Stryker.
Competitors of Artelon
Artelon has 3 listed competitors in our database, 2 of them funded. They include Theradaptive, Aziyo Biologics and MiMedx Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| theradaptive.com | 2004 | Boston, United States | $32.2M | 21 | Therapeutic delivery platform is developed for orthopedic clinical indications. | |
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| mimedx.com | 1985 | Marietta, United States | 735 | Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics |
Detailed competitors of Artelon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Artelon
The website of Artelon (artelon.com) receives about 1K visits a month.
- Monthly visits1K
▼ 56.2% vs previous month
Top companies in Orthopedics
3 companies that operate in the same segment as Artelon (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Artelon
Complete news archive for Artelon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Artelon
Artelon was founded in 1986 and raised its 1st funding round 37 years after it was founded.
Artelon is headquartered in Marietta, United States. It is registered at Marietta, Georgia, United States.
Aaron Smith is the CEO of Artelon, as recorded in our data.
Artelon is a funded company, having raised a total of $20M across 1 funding round to date. The company's 1st funding round was a Series B of $20M, raised on May 2023.
Artelon was founded in 1986 and is headquartered in Marietta, United States. Biomaterials are developed by the company for regenerative medicine, targeting soft tissue reconstruction in tendons and ligaments. Solutions are provided for pain management, functional restoration, arthritis treatment, and deformity correction. Elasticity is enhanced in healing tissues to support natural motion, within the medical devices and biotechnology sector.
Artelon's top competitors include Theradaptive, MiMedx Group and Aziyo Biologics.
Artelon offers FLEXBAND.
Artelon has 2 investors. Key investors include Stryker, and Vensana Capital.
Yes. Artelon was acquired by Stryker in June 2024.